Company: BNBX
Filing Date: 2025-11-04
Form Type: 424B5
Source: 0001104659-25-105958
Chunk: 21

Company: BNB PLUS CORP.
Filing Date: 2025-11-04
Form: 424B5
Chunk 21
---
 approximately 60%. We estimate that we will
incur aggregate pre-tax charges of approximately $1.4 million in connection with the reduction-in-force, primarily consisting of severance
payments, employee benefits, and related costs. The reduction-in-force was substantially completed by October 31, 2025 and the associated
charges will be recorded in the first quarter of fiscal 2026. We estimate that the restructuring will result in annualized cost savings
of approximately $2.9 million. The estimated charges that we expect to incur are subject to a number of assumptions, and actual results
may differ materially from these estimates. We may also incur additional costs not currently contemplated due to events that may occur
as a result of, or that are associated with, the restructuring plan.

Summary of Risk Factors

Participating in this offering involves significant
risks. You should carefully consider all of the information in this prospectus supplement before making an investment in our common stock.
Below please find a summary of the principal risks we face, organized under relevant headings. These risks are discussed more fully in
the section titled “Risk Factors” on page S-15 of this prospectus supplement, page 3 of the accompanying prospectus,
in our Annual Report on Form 10-K for our most recent fiscal year filed with the SEC, subsequent Quarterly Reports on Form 10-Q,
any amendment or updates thereto reflected in subsequent filings with the SEC, Exhibit 99.3 to our Current Report on Form 8-K
filed on October 1, 2025 and in other reports we file with the SEC that are incorporated by reference herein.

| S-10 |

Risks Relating to this Offering:

| · | Management will have broad discretion as to the                                                                                        
 use of the proceeds from this offering, and we may use the proceeds in ways in which you and other stockholders may disagree;          |
| · | You will experience immediate and substantial                                                                                          
 dilution in the net tangible book value per share of the common stock you purchase;                                                    |
| · | Raising additional funds by issuing securities                                                                                         
 or through licensing arrangements may cause dilution to stockholders, restrict our operations or require us to relinquish proprietary  
 rights;                                                                                                                                |
| · | Sales of a significant number of shares of our                                                                                         
 common stock in the public markets, or the perception that such sales could occur, could depress the market price of our common stock; 
 and                                                                                                                                    |
| · | You may experience future dilution as